Antimicrobial Activity of Compounds Isolated from Uvaria wrayi (King) L.L. Zhou, Y.C.F. Su & R.M.K. Saunders Leaves and Twigs.

Antimicrobial resistance (AMR) refers to the capacity of bacteria to resist the impact of antibiotics, emerging as a significant global health concern. To discover novel antibacterial agents, the isolation and elucidation of compounds from leaf and twig extracts of Uvaria wrayi (King) L.L. Zhou, Y.C.F. Su & R.M.K. Saunders were investigated for the first time. 9 known compounds were performed and categorized as polyoxygenated cyclohexenes (1-3), seco-cyclohexenes (4), acrylamide derivatives (5,6), and aristolactam alkaloids (7-9). All isolated compounds were evaluated for their antimicrobial activities against 5 Gram-positive bacteria, including Staphylococcus aureus (TISTR 746), Staphylococcus epidermidis (DMST 15505), Methicillin-resistant Staphylococcus aureus (MRSA) (NPRC 001R), Cutibacterium acnes (formerly Propionibacterium acnes) (DMST 14916), and Streptococcus mutans (DMST 18777/ATCC 25175T). 2 Gram-negative bacteria, Shigella flexneri (DMST 4423) and Salmonella enterica ser. typhimurium (TISTR 2519) were evaluated. Most of the isolated compounds displayed moderate antimicrobial activity with a MIC value of 64 µg/mL, except compounds 1,9 showed antibacterial against MRSA with a MIC value of 128 µg/mL. Compounds 2-9 exhibited antimicrobial activity against C. acnes (DMST 14916) with a MIC value of 32 µg/mL. Compounds 1-3, 6, and 7 also responded to inhibit C. acnes with the same MBC value of 128 µg/mL. This exploration holds promise for advancing our understanding of potential antibacterial compounds within U. wrayi and addressing the challenges posed by antimicrobial resistance. [ABSTRACT FROM AUTHOR]